Furthermore, compared to single treatments, the combination of carboplatin and KHSRP knockdown further reduced KHSRP, HMGB1, N-cadherin, vimentin, and Ki67 levels, and increased E-cadherin levels in mouse tumor tissues (Fig. 6A-G). The gene discussed is CDH2; the disease is neoplasm.